ATE366113T1 - Verwendung von n2o zur behandlung von postischemischen cerebralen zellulären beschädigungen - Google Patents
Verwendung von n2o zur behandlung von postischemischen cerebralen zellulären beschädigungenInfo
- Publication number
- ATE366113T1 ATE366113T1 AT04300008T AT04300008T ATE366113T1 AT E366113 T1 ATE366113 T1 AT E366113T1 AT 04300008 T AT04300008 T AT 04300008T AT 04300008 T AT04300008 T AT 04300008T AT E366113 T1 ATE366113 T1 AT E366113T1
- Authority
- AT
- Austria
- Prior art keywords
- treat
- cellular damage
- vol
- postischemic cerebral
- xenon
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Inorganic Chemistry (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurosurgery (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Organic Chemistry (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR0350002A FR2849779B1 (fr) | 2003-01-15 | 2003-01-15 | Utilisation de xenon ou de n2o dans le traitement des deteriorations cellulaires cerebrales post-ischemiques |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE366113T1 true ATE366113T1 (de) | 2007-07-15 |
Family
ID=32525026
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT04300008T ATE366113T1 (de) | 2003-01-15 | 2004-01-06 | Verwendung von n2o zur behandlung von postischemischen cerebralen zellulären beschädigungen |
Country Status (9)
| Country | Link |
|---|---|
| US (1) | US7405241B2 (de) |
| EP (1) | EP1438963B1 (de) |
| AT (1) | ATE366113T1 (de) |
| CA (1) | CA2453053A1 (de) |
| DE (1) | DE602004007304T2 (de) |
| DK (1) | DK1438963T3 (de) |
| ES (1) | ES2289458T3 (de) |
| FR (1) | FR2849779B1 (de) |
| PT (1) | PT1438963E (de) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| SG171470A1 (en) * | 2003-04-09 | 2011-06-29 | Osmose Inc | Micronized wood preservative formulations |
| US8637089B2 (en) | 2003-04-09 | 2014-01-28 | Osmose, Inc. | Micronized wood preservative formulations |
| WO2008132239A1 (en) * | 2007-04-30 | 2008-11-06 | Nnoxe Pharmaceutiques Inc | Pharmaceutical composition comprising at least one thrombolytic agent (a) and at least one gas (b) selected from the group consisting of nitrous oxide, argon, xenon, helium, neon |
| CN110464709A (zh) | 2012-08-10 | 2019-11-19 | 德克萨斯州大学系统董事会 | 用于治疗中风的神经保护性脂质体组合物和方法 |
| CN105228591B (zh) | 2013-03-15 | 2019-08-13 | 德克萨斯州大学系统董事会 | 富含稀有气体的液体及其制备和使用方法 |
| EP4312560A4 (de) * | 2021-04-02 | 2025-02-19 | Peter Nagele | Zusammensetzungen und verfahren zur behandlung von behandlungsresistenten depressiven erkrankungen mit stickoxid |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3876773A (en) * | 1973-05-15 | 1975-04-08 | British Oxygen Co Ltd | Gas mixtures containing nitrous oxide |
| FR2596989B1 (fr) * | 1986-04-14 | 1990-05-18 | Air Liquide | Produit de radiosensibilisation des tissus biologiques en radiotherapie |
| AU2789192A (en) * | 1991-10-04 | 1993-05-03 | Mallinckrodt Medical, Inc. | Gaseous ultrasound contrast agents |
| RU2072241C1 (ru) * | 1995-09-20 | 1997-01-27 | Панина Елена Владимировна | Способ формирования дыхательной газовой смеси и аппарат для его осуществления |
| FR2812197B1 (fr) * | 2000-07-27 | 2003-01-03 | Air Liquide Sante Int | Utilisation de co dans le traitement de l'inflammation des voies aeriennes superieures ou des bronches |
| FR2812545B1 (fr) * | 2000-08-03 | 2003-03-28 | Air Liquide Sante Int | Aerosol medicamenteux inhalable dans le traitement ou la prevention de la douceur |
-
2003
- 2003-01-15 FR FR0350002A patent/FR2849779B1/fr not_active Expired - Fee Related
- 2003-12-30 CA CA002453053A patent/CA2453053A1/fr not_active Abandoned
-
2004
- 2004-01-06 EP EP04300008A patent/EP1438963B1/de not_active Expired - Lifetime
- 2004-01-06 DK DK04300008T patent/DK1438963T3/da active
- 2004-01-06 AT AT04300008T patent/ATE366113T1/de active
- 2004-01-06 ES ES04300008T patent/ES2289458T3/es not_active Expired - Lifetime
- 2004-01-06 PT PT04300008T patent/PT1438963E/pt unknown
- 2004-01-06 DE DE602004007304T patent/DE602004007304T2/de not_active Expired - Lifetime
- 2004-01-15 US US10/758,513 patent/US7405241B2/en not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| DE602004007304T2 (de) | 2008-03-13 |
| DE602004007304D1 (de) | 2007-08-16 |
| US7405241B2 (en) | 2008-07-29 |
| CA2453053A1 (fr) | 2004-07-15 |
| DK1438963T3 (da) | 2007-10-01 |
| EP1438963A1 (de) | 2004-07-21 |
| PT1438963E (pt) | 2007-09-11 |
| FR2849779A1 (fr) | 2004-07-16 |
| EP1438963B1 (de) | 2007-07-04 |
| US20040258766A1 (en) | 2004-12-23 |
| ES2289458T3 (es) | 2008-02-01 |
| FR2849779B1 (fr) | 2006-07-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SE0301882D0 (sv) | New use I | |
| DE602004013792D1 (de) | Verwendung von c-kit-inhibitoren für die behandlung von typ-2-diabetes | |
| NO20053742L (no) | Tri (cyclo)-substituerte amidforbindelser | |
| ATE489957T1 (de) | Mittel zur behandlung von entzündlichen erkrankungen | |
| NO20065260L (no) | Tri(cyklo)substituerte amidforbindelser | |
| EA200700074A1 (ru) | Способ повышения скорости заживления повреждения ( варианты ), устройство доставки перекиси водорода и композиция для лечения повреждений у млекопитающих | |
| DK1301201T3 (da) | Behandling af glycogenosis type II | |
| ATE373474T1 (de) | Substituierte 2-aminotetraline zur behandlung von depressionen | |
| DK1758860T3 (da) | Mættede og umættede 3-pyridylbenzocykloalkylmethylaminer til behandling af smerter, depressioner og angsttilstande | |
| EA200700848A1 (ru) | Ингибиторы pi3-гамма-киназы для лечения анемии | |
| DE60203847D1 (de) | Verbindungen enthaltend S-Tofisopam sowie Verwendung dieser Verbindungen zur Herstellung eines Medikamentes zur Behandlung oder Prophylaxe von Krämpfen und Anfällen | |
| MXPA05012320A (es) | Tratamientos de trastornos bipolares y sintomas asociados. | |
| ATE366113T1 (de) | Verwendung von n2o zur behandlung von postischemischen cerebralen zellulären beschädigungen | |
| DE60129829D1 (de) | Zyklisierte benzamid-neurokinin-antagonisten zur verwendung in therapie | |
| ECSP055844A (es) | Nuevos compuestos triciclicos | |
| UA83821C2 (ru) | Производные бензолсульфонамидов, способ их получения и их применение для лечения воспалительных заболеваний и утоления боли | |
| DE59914712D1 (de) | Verwendung von inhibitoren des kqt1-kanals zur herstellung eines medikaments zur behandlung von krankheiten, die durch helminthen und ektoparasiten hervorgerufen werden | |
| ATE422892T1 (de) | Verwendung von hyaluronsäure zur herstellung von zusammensetzungen zur behandlung rekurrenten aphthen in der mundhöhle | |
| ATE367167T1 (de) | Aufbereitung von aldesleukin zur pharmazeutischen verwendung | |
| CY1107562T1 (el) | Χρηση των ν-(2-αρυλ-προπιονυλ)-σουκλφοναμιδιων για τη θepαπεια του τραυματος του νωτιαιου μυελου | |
| WO2005060960A3 (en) | Use of histamine to treat bone disease | |
| DE60220512D1 (de) | Verwendung von flumazenil zur herstellung eines medikaments für die behandlung von kokainabhängigkeit | |
| ATE252383T1 (de) | Verwendung von 2-methyl-thiazolidin-2,4- dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen | |
| DE602004016126D1 (de) | Aplidine zur behandlung von multiplem myelom | |
| DE602004030661D1 (de) | Verwendung von kahalalide verbindungen zur herstellung eines arzneimittels zur behandlung von psoriasis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification |
Ref document number: 1438963 Country of ref document: EP |